|
Re: Epigenetics and Coronavirus
|
4
|
Resverlogix Corp.
|
Mar 23, 2020 11:22AM
|
|
Re: Epigenetics market size
|
1
|
Zenith Epigenetics
|
Jan 16, 2024 07:41PM
|
|
Re: Epigenetics market size
|
6
|
Zenith Epigenetics
|
Jan 16, 2024 02:18PM
|
|
Re: ESC Poster on Vascular Inflammation, Calcification and Plaque Vulnerability
|
2
|
Resverlogix Corp.
|
Sep 03, 2019 07:45PM
|
|
Re: Ethics Approval?
|
2
|
Resverlogix Corp.
|
Oct 12, 2021 05:35PM
|
|
Re: Ethics Approval?
|
|
Resverlogix Corp.
|
Oct 12, 2021 07:39PM
|
|
Re: Ethics Approval?
|
2
|
Resverlogix Corp.
|
Oct 13, 2021 04:28PM
|
|
Re: Eversana
|
3
|
Resverlogix Corp.
|
Jul 08, 2021 10:48AM
|
|
Re: Eversana??
|
1
|
Resverlogix Corp.
|
Jan 08, 2024 10:01AM
|
|
Re: everything r v x is down 4% to around 24%
|
6
|
Resverlogix Corp.
|
Jan 27, 2021 01:17PM
|
|
Re: Exempt Distribution
|
2
|
Resverlogix Corp.
|
Feb 17, 2021 03:30PM
|
|
Re: Exempt Distribution - 2022-04-14
|
8
|
Resverlogix Corp.
|
Apr 19, 2022 11:23AM
|
|
Re: Exempt Distribution - 2022-04-14
|
6
|
Resverlogix Corp.
|
Apr 18, 2022 11:21AM
|
|
Re: Exempt Distribution - 2022-04-14
|
6
|
Resverlogix Corp.
|
Apr 18, 2022 01:28PM
|
|
Re: Exposure in Motley Fool....
|
1
|
Resverlogix Corp.
|
Oct 09, 2019 09:37AM
|
|
Re: Fair warning to everyone here....
|
2
|
Resverlogix Corp.
|
Jun 25, 2019 09:16AM
|
|
Re: Fair warning to everyone here....
|
7
|
Resverlogix Corp.
|
Jun 25, 2019 05:27PM
|
|
Re: FDA Breakthrough Therapy Designation -- A "Fast Track" program? Day 120
|
4
|
Resverlogix Corp.
|
May 11, 2020 11:25AM
|
|
Re: FDA Breakthrough Therapy Designation -- A "Fast Track" program? Day 120
|
5
|
Resverlogix Corp.
|
May 11, 2020 12:09PM
|
|
Re: FDA busts Merck's Keytruda in triple-negative breast cancer with a CRL — not unexpected given its disastrous adcomm
|
1
|
Zenith Epigenetics
|
Mar 30, 2021 02:46PM
|
